Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.
2.

Nonionic Microemulsions as Solubilizers of Hydrophobic Drugs: Solubilization of Paclitaxel.

Lo JT, Lee TM, Chen BH.

Materials (Basel). 2016 Sep 7;9(9). pii: E761. doi: 10.3390/ma9090761.

3.

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer.

Raghavan R, Hyter S, Pathak HB, Godwin AK, Konecny G, Wang C, Goode EL, Fridley BL.

BMC Genomics. 2016 Oct 19;17(1):811.

4.

Prediction of multidimensional drug dose responses based on measurements of drug pairs.

Zimmer A, Katzir I, Dekel E, Mayo AE, Alon U.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10442-7. doi: 10.1073/pnas.1606301113. Epub 2016 Aug 25.

5.

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.

Fridley BL, Ghosh TM, Wang A, Raghavan R, Dai J, Goode EL, Lamba JK.

Front Genet. 2016 Mar 22;7:37. doi: 10.3389/fgene.2016.00037. eCollection 2016.

6.

A physiologically-based flow network model for hepatic drug elimination III: 2D/3D DLA lobule models.

Rezania V, Coombe D, Tuszynski JA.

Theor Biol Med Model. 2016 Mar 3;13:9. doi: 10.1186/s12976-016-0034-5.

7.

Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer.

Martin SK, Pu H, Penticuff JC, Cao Z, Horbinski C, Kyprianou N.

Cancer Res. 2016 Feb 15;76(4):912-26. doi: 10.1158/0008-5472.CAN-15-2078. Epub 2015 Dec 8.

8.

A Rare Case of Paclitaxel and/or Trastuzumab Induced Acute Hepatic Necrosis.

Mandaliya H, Baghi P, Prawira A, George MK.

Case Rep Oncol Med. 2015;2015:825603. doi: 10.1155/2015/825603. Epub 2015 Oct 29.

9.
10.

Aqueous extract from taxus baccata inhibits adenosine deaminase activity significantly in cancerous and noncancerous human gastric and colon tissues.

Durak ZE, Büber S, Devrim E, Kocaoğlu H, Durak I.

Pharmacogn Mag. 2014 Apr;10(Suppl 2):S214-6. doi: 10.4103/0973-1296.133232.

11.

Role of pregnane X receptor in chemotherapeutic treatment.

Zhuo W, Hu L, Lv J, Wang H, Zhou H, Fan L.

Cancer Chemother Pharmacol. 2014 Aug;74(2):217-27. doi: 10.1007/s00280-014-2494-9. Epub 2014 Jun 3. Review.

12.

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

Reddy SK, Reilly C, Zhan M, Mindikoglu AL, Jiang Y, Lane BF, Alexander HR, Culpepper WJ, El-Kamary SS.

Med Oncol. 2014 Jun;31(6):971. doi: 10.1007/s12032-014-0971-y. Epub 2014 May 6.

13.

Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity.

Chiang PC, Gould S, Nannini M, Qin A, Deng Y, Arrazate A, Kam KR, Ran Y, Wong H.

Nanoscale Res Lett. 2014 Apr 1;9(1):156. doi: 10.1186/1556-276X-9-156.

14.

Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range.

Wang EC, Sinnott R, Werner ME, Sethi M, Whitehurst AW, Wang AZ.

Nanomedicine. 2014 Feb;10(2):321-8. doi: 10.1016/j.nano.2013.07.012. Epub 2013 Aug 3.

15.

Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.

Krens SD, McLeod HL, Hertz DL.

Pharmacogenomics. 2013 Apr;14(5):555-74. doi: 10.2217/pgs.13.33.

16.

Synthesis and Biological Evaluation of a Biotinylated Paclitaxel With an Extra-Long Chain Spacer Arm.

Lis LG, Smart MA, Luchniak A, Gupta ML Jr, Gurvich VJ.

ACS Med Chem Lett. 2012 Sep 13;3(9):745-748. Epub 2012 Jul 30.

17.

Sensitivity and mechanisms of taxol-resistant prostate adenocarcinoma cells to Vernonia amygdalina extract.

Cameron KS, Howard CB, Izevbigie EB, Hill BJ, Tchounwou PB.

Exp Toxicol Pathol. 2013 Sep;65(6):759-65. doi: 10.1016/j.etp.2012.11.002. Epub 2012 Dec 11.

18.

Pharmacokinetic evaluation of Paclitaxel in South Indian cancer patients: a prospective study.

Vasantha J, Kannan G, Goud T, Palani T, Vanitha R, Anitha R, Priya J.

J Young Pharm. 2011 Oct;3(4):322-8. doi: 10.4103/0975-1483.90245.

19.

Taxane pathway.

Oshiro C, Marsh S, McLeod H, Carrillo MW, Klein T, Altman R.

Pharmacogenet Genomics. 2009 Dec;19(12):979-83. doi: 10.1097/FPC.0b013e3283335277. No abstract available.

20.

Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice.

Oostendorp RL, Buckle T, Lambert G, Garrigue JS, Beijnen JH, Schellens JH, van Tellingen O.

Invest New Drugs. 2010 Apr 13;29(5):768-76. Print 2011 Oct.

Supplemental Content

Support Center